The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870
Open accessAbstract
Sepsis and meningitis caused by serogroup B meningococcus are devastating diseases of infants and young adults, which cannot yet be prevented by vaccination. By genome mining, we discovered GNA1870, a new surface-exposed lipoprotein of Neisseria meningitidis that induces high levels of bactericidal antibodies. The antigen is expressed by all strains of N. meningitidis tested. Sequencing of the gene in 71 strains representative of the genetic and geographic diversity of the N. meningitidis population, showed that the protein can be divided into three variants. Conservation within each variant ranges between 91.6 to 100%, while between the variants the conservation can be as low as 62.8%. The level of expression varies between strains, which can be classified as high, intermediate, and low expressors. Antibodies against a recombinant form of the protein elicit complement-mediated killing of the strains that carry the same variant and induce passive protection in the infant rat model. Bactericidal titers are highest against those strains expressing high yields of the protein; however, even the very low expressors are efficiently killed. The novel antigen is a top candidate for the development of a new vaccine against meningococcus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Maiden, M. C. J., Bygraves, J. A., Feil, E., Morelli, G., Russell, J. E., Urwin, R., Zhang, Q., Zhou, J., Zurth, K., Caugant, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3140 · Cited by 3,833
Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome Sequencing
Pizza, M., Scarlato, V., Masignani, V., Giuliani, M. M., Aricò, B., Comanducci, M., Jennings, G. T., Baldi, L., Bartolini, E., Capecchi, B., et al. (2000) · Science · doi:10.1126/science.287.5459.1816 · Cited by 1,399
Self-citationComplete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58
Tettelin, H., Saunders, N. J., Heidelberg, J., Jeffries, A. C., Nelson, K. E., Eisen, J. A., Ketchum, K. A., Hood, D. W., Peden, J. F., Dodson, R. J., et al. (2000) · Science · doi:10.1126/science.287.5459.1809 · Cited by 1,097
Self-citationHUMAN IMMUNITY TO THE MENINGOCOCCUS
Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1327 · Cited by 995
Universities and tobacco money: Some universities are accomplices in the tobacco epidemic
Cohen, J. E. (2001) · BMJ · doi:10.1136/bmj.323.7303.1 · Cited by 943
Expert system for predicting protein localization sites in gram‐negative bacteria
Nakai, K., & Kanehisa, M. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340110203 · Cited by 746
Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491
Parkhill, J., Achtman, M., James, K. D., Bentley, S. D., Churcher, C., Klee, S. R., Morelli, G., Basham, D., Brown, D., Chillingworth, T., et al. (2000) · Nature · doi:10.1038/35006655 · Cited by 704
Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway
Bjune, G., Høiby, E. A., Grønnesby, J. K., Arnesen, Ø., Fredriksen, J. H., Lindbak, A.-K., Nøkleby, H., Rosenqvist, E., Solberg, L. K., Closs, O., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)91961-s · Cited by 694
de Lorenzo, V, Wee, S., Herrero, M., & Neilands, J. B. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.6.2624-2630.1987 · Cited by 536 · cited 1×
“coli consensus (29) and allowing a maximum of nine mismatches.”
BackgroundSierra, G. V. G., Campa, H. C., Varcacel, N. M., Garcia, I. L., Izquierdo, P., Sotolongo, P. F., Casanueva, G. V., Rico, C. O., Rodriguez, C. R., & Terry, M. H. (1991) · PubMed · Cited by 512
The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996
Rosenstein, N. E., Perkins, B. A., Stephens, D. S., Lefkowitz, L., Cartter, M. L., Danila, R., Cieslak, P., Shutt, K. A., Popovic, T., Schuchat, A., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/315158 · Cited by 449
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Gotschlich, E. C., Goldschneider, I., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1367 · Cited by 402
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Gotschlich, E. C., Liu, T. Y., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1349 · Cited by 396
Tappero, J. W., Lagos, R., Maldonado Ballesteros, A., Plikaytis, B., Williams, D., Dykes, J., Gheesling, L. L., Carlone, G. M., Høiby, E. A., Holst, J., et al. (1999) · JAMA · doi:10.1001/jama.281.16.1520 · Cited by 369
NadA, a Novel Vaccine Candidate of Neisseria meningitidis
Comanducci, M., Bambini, S., Brunelli, B., Adu-Bobie, J., Aricò, B., Capecchi, B., Giuliani, M. M., Masignani, V., Santini, L., Savino, S., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020407 · Cited by 351
Self-citationA single amino acid determinant of the membrane localization of lipoproteins in E. coli
Yamaguchi, K., Yu, F., & Inouye, M. (1988) · Cell · doi:10.1016/0092-8674(88)90162-6 · Cited by 343
Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England
Ramsay, M. E., Andrews, N., Kaczmarski, E. B., & Miller, E. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03594-7 · Cited by 338
Finne, J., Bitter-Suermann, D., Goridis, C., & Finne, U. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.12.4402 · Cited by 332
Meningitis in infancy in England and Wales: follow up at age 5 years
Bedford, H., de Louvois, J., Halket, S., Peckham, C., Hurley, R., & Harvey, D. (2001) · BMJ · doi:10.1136/bmj.323.7312.533 · Cited by 308
Population genetics and molecular epidemiology of Neisseria meningitidis
CAUGANT, D. A. (1998) · APMIS · doi:10.1111/j.1699-0463.1998.tb01379.x · Cited by 255
Development of vaccines against meningococcal disease
Jódar, L., Feavers, I. M., Salisbury, D., & Granoff, D. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08416-7 · Cited by 250
Self-citationGrifantini, R., Bartolini, E., Muzzi, A., Draghi, M., Frigimelica, E., Berger, J., Ratti, G., Petracca, R., Galli, G., Agnusdei, M., et al. (2002) · Nature Biotechnology · doi:10.1038/nbt728 · Cited by 205
Self-citationPerkins, B. A., Jonsdottir, K., Briem, H., Griffiths, E., Plikaytis, B. D., Hoiby, E. A., Rosenqvist, E., Holst, J., Nokleby, H., Sotolongo, F., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/514232 · Cited by 171
Complications and sequelae of meningococcalinfections in children
Edwards, M. S., & Baker, C. J. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80250-8 · Cited by 154
Granoff, D. M., Bartoloni, A., Ricci, S., Gallo, E. R., Rosa, D., Ravenscroft, N., Guarnieri, V., Seid, R. C., Shan, A., Usinger, W. R., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.5028 · Cited by 88
Self-citationSEROLOGICAL RELATIONSHIPS AMONG MENINGOCOCCI
Branham, S. E. (1953) · Bacteriological Reviews · doi:10.1128/br.17.3.175-188.1953 · Cited by 84
Cartwright, K., Noah, N. D., & Peltola, H. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00205-5 · Cited by 82
Turner, D. P. J., Wooldridge, K. G., & Ala’Aldeen, D. A. A. (2002) · Infection and Immunity · doi:10.1128/iai.70.8.4447-4461.2002 · Cited by 71
Schlegel, A., Danot, O., Richet, E., Ferenci, T., & Boos, W. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.11.3069-3077.2002 · Cited by 44
Strutzberg‐Minder, K., von Olleschik-Elbheim, L., Franz, B., Pyne, C., Schmidt, M. A., & Gerlach, G. F. (1995) · Infection and Immunity · doi:10.1128/iai.63.10.3846-3850.1995 · Cited by 23
Cited by
A universal vaccine for serogroup B meningococcus
Giuliani, M. M., Adu-Bobie, J., Comanducci, M., Aricò, B., Savino, S., Santini, L., Brunelli, B., Bambini, S., Biolchi, A., Capecchi, B., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603940103 · Cited by 727
Self-citationLipoproteins of Bacterial Pathogens
Kovacs-Simon, A., Titball, R. W., & Michell, S. L. (2011) · Infection and Immunity · doi:10.1128/iai.00682-10 · Cited by 440
Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy
Ram, S., Lewis, L. A., & Rice, P. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00048-09 · Cited by 405
Serruto, D., Bottomley, M. J., Ram, S., Giuliani, M. M., & Rappuoli, R. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.033 · Cited by 404
Self-citationMadico, G., Welsch, J. A., Lewis, L. A., McNaughton, A., Perlman, D. H., Costello, C. E., Ngampasutadol, J., Vogel, U., Granoff, D. M., & Ram, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.501 · Cited by 390
Self-citation
Metadata
- Authors
- Masignani, V., Comanducci, M., Giuliani, M. M., Bambini, S., Adu-Bobie, J., Aricò, B., Brunelli, B., Pieri, A., Santini, L., Savino, S., Serruto, D., Litt, D., Kroll, S., Welsch, J. A., Granoff, D. M., Rappuoli, R., & Pizza, M.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-03-17
- Volume
- 197
- Issue
- 6
- Pages
- 789-799
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W1975355256
- Cited by
- 395
- References
- 32
- FWCI
- 10.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.